Genmab A/S
GMAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,844 | $5,637 | $7,035 | $3,983 |
| Dep. & Amort. | $413 | $295 | $362 | $248 |
| Deferred Tax | $0 | $122 | $0 | -$546 |
| Stock-Based Comp. | $721 | $586 | $439 | $310 |
| Change in WC | -$1,595 | $1,362 | -$1,930 | -$770 |
| Other Non-Cash | $388 | -$622 | -$1,994 | -$997 |
| Operating Cash Flow | $7,771 | $7,380 | $3,912 | $2,228 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$187 | -$366 | -$317 | -$252 |
| Net Acquisitions | -$12,246 | $0 | $2,444 | $709 |
| Inv. Purchases | -$8,636 | -$10,907 | -$9,698 | -$15,616 |
| Inv. Sales/Matur. | $11,279 | $10,001 | $7,254 | $14,907 |
| Other Inv. Act. | -$117 | -$10 | -$2,444 | -$709 |
| Investing Cash Flow | -$9,907 | -$1,282 | -$2,761 | -$961 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60 | -$91 | -$73 | -$58 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$3,988 | -$564 | -$908 | -$447 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $129 | $49 | $192 | $85 |
| Financing Cash Flow | -$3,919 | -$606 | -$789 | -$420 |
| Forex Effect | $1,046 | -$518 | $574 | $850 |
| Net Chg. in Cash | -$5,009 | $4,974 | $936 | $1,697 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,867 | $9,893 | $8,957 | $7,260 |
| End Cash | $9,858 | $14,867 | $9,893 | $8,957 |
| Free Cash Flow | $7,584 | $7,004 | $3,595 | $1,976 |